Bill Kohlbrenner

Bill is a pharma and biotech veteran who joined BioLoomics in 2021. Prior to that, he was CEO at NeuroLucent, a start-up focused on Alzheimer’s. Bill is also CSO at Life Science Nation (LSN), which offers fund-raising services to early-stage companies. Prior to LSN, Bill was a BD executive at AbbVie where he led a global scouting team. Earlier in his career, he directed drug discovery programs in oncology, antivirals, and antibacterials.